Novel Drug Reduced Bulging in Active and Chronic Thyroid Eye Disease

(MedPage Today) -- ORLANDO -- Infusions of the investigational monoclonal antibody veligrotug improved symptoms among patients with active and chronic thyroid eye disease, the phase III THRIVE clinical program showed.
By week 15 in 113 patients...